0001654954-24-007460.txt : 20240606 0001654954-24-007460.hdr.sgml : 20240606 20240606182529 ACCESSION NUMBER: 0001654954-24-007460 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240605 FILED AS OF DATE: 20240606 DATE AS OF CHANGE: 20240606 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PAYNE JOHN BERNARD CENTRAL INDEX KEY: 0001582392 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40449 FILM NUMBER: 241026696 MAIL ADDRESS: STREET 1: 9900 NE 114TH CIRCLE CITY: VANCOUVER STATE: WA ZIP: 98662 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zivo Bioscience, Inc. CENTRAL INDEX KEY: 0001101026 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 870699977 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 E. LONG LAKE ROAD STREET 2: SUITE 100 CITY: BLOOMFIELD HILLS STATE: MI ZIP: 48304 BUSINESS PHONE: (248) 452 9866 MAIL ADDRESS: STREET 1: 21 E. LONG LAKE ROAD STREET 2: SUITE 100 CITY: BLOOMFIELD HILLS STATE: MI ZIP: 48304 FORMER COMPANY: FORMER CONFORMED NAME: HEALTH ENHANCEMENT PRODUCTS INC DATE OF NAME CHANGE: 20040202 FORMER COMPANY: FORMER CONFORMED NAME: WESTERN GLORY HOLE INC DATE OF NAME CHANGE: 19991215 4 1 section16.xml FORM 4 X0508 4 2024-06-05 0001101026 Zivo Bioscience, Inc. ZIVO 0001582392 PAYNE JOHN BERNARD 9900 NE 114TH CIRCLE VANCOUVER WA 98662 true true false false President and CEO false Nonstatutory Stock Option to Purchase Common Stock 26.88 2024-06-05 4 D false 1902 D 2031-10-11 Common Stock 1902 0 D Nonstatutory Stock Option to Purchase Common Stock 33.00 2024-06-05 4 D false 32000 D 2031-10-20 Common Stock 32000 0 D Nonstatutory Stock Option to Purchase Common Stock 17.16 2024-06-05 4 D false 31836 D 2032-12-15 Common Stock 31836 0 D Nonstatutory Stock Option to Purchase Common Stock 7.96 2024-06-05 4 A false 167180 A 2034-06-04 Common Stock 167180 167180 D Nonstatutory Stock Option to Purchase Common Stock 7.96 2024-06-05 4 A false 50251 0 A 2034-06-04 Common Stock 50251 50251 D The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023. The canceled options were fully vested. The Issuer canceled options for an aggregate 65,738 shares of the Issuer's common stock granted to the Reporting Person on 10/12/2021, 10/21/2021, and 12/16/2022. In exchange for the canceled options, the Reporting Person received a replacement option, for 167,180 shares, having an exercise price of $7.96. The option was issued pursuant to the 2021 Equity Incentive Plan and all options vested immediately upon the date of acceptance of grant. /s/ John B. Payne 2024-06-06